Original Research

Antibiotic Susceptibility Profiling, Molecular Characterization, and16S rRNA-Based Phylogenetic Analysis of Pseudomonas Aeruginosa Isolates from Musculoskeletal Infections

DOI https://doi.org/10.70302/jpsim.v6i2.2535
Received: 09 Jan 2025 Revised: 25 Feb 2025 Accepted: 28 Apr 2025 Published Online: 05 Jun 2025

Abstract

Objective

The primary goal of this research was to describe antibiotic resistance and identification of virulence genes in Pseudomonas aeruginosa.

Methods

The study was cross-sectional, featuring a randomized selection of samples. Conducted from January to December 2023, the study encompassed a sample size of 320 including blood, pus, and wound swabs [Male:169(52.8%), Female 151(47.1%)]. Age-based categories were ascertained, G1:13-20 years, G2:21-40 years, G3:41-60 years, G4:61-80 years. Identification tests for Pseudomonas aeruginosa included API20NE (bioMérieux®, France). Antimicrobial susceptibility testing was following the CLSI,2020 for the Disc Diffusion Test.DNA extraction and purification were carried out through a Genome Jet DNA Purification kit and 16S rRNA primers for the identification of resistance genes exoA and oprL. Phylogenetic and taxonomic identification was conducted via ribosomal RNA sequencing of PCR-amplified products(BIO-RAD T100TM Thermocycler) and sequencing with an automated sequencer (Illumina MiniSeqTM). Phylogenetic tree was constructed by MEGA11.p-value<0.05 was statistically significant.

Results

Prevalence of Pseudomonas aeruginosa was 22%. Positivity was recorded from pus (152/320:47.5%),blood(124/320-38.75%) and wound swabs(44/320-1 3.75%).G4 showed maximum positive isolates(91.25%).Maximum resistance was exhibited against Meropenem(76%) and Imipenem(70%).PCR identified the presence of resistance genes,exoA gene(125 bp), and oprL(105 bp). The phylogenetic tree was constructed through ribosomal RNA.The gene bank accession number for 16S rRNA gene of P. aeruginosa is PQ269824.

Conclusion

Antimicrobial susceptibility testing helps improve the treatment alternatives for stubborn strains. The presence of resistance genes highlights how research at the molecular level enhances treatment approaches for managing multi-drug resistant pathogens.

Keywords
Pseudomonas aeruginosa antibiotic susceptibility musculoskeletal infections phylogenetic tree.

How to Cite This Article

Batool W, Muddassir M, Iqbal MJ, Ghaffar A, Ali MQ, Naqvi SZH. Antibiotic Susceptibility Profiling, Molecular Characterization, and16S rRNA-Based Phylogenetic Analysis of Pseudomonas Aeruginosa Isolates from Musculoskeletal Infections. J Pak Soc Intern Med. 2025;6(2):185–190. doi:10.70302/jpsim.v6i2.2535

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Kolinsky DC, Liang SY. Musculoskeletal Infections in the Emergency Department. Emerg Med Clin North Am. 2018;36(4):751-66.
  2. Diggle SP, Whiteley M. Microbe Profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat. Microbiology (Reading). 2020;166(1):30-3.
  3. Saeed K, Sendi P, Arnold WV, Bauer TW, Coraça-Huber DC, Chen AF et al. Bacterial toxins in musculoskeletal infections. J Orthop Res. 2021;39(2):240-50.
  4. Earwood JS, Walker TR, Sue GJC. Septic Arthritis: Diagnosis and Treatment. Am Fam Physician. 2021;104(6):589-97.
  5. Azam MW, Khan AU. Updates on the pathogenicity status of Pseudomonas aeruginosa. Drug Discovery Today. 2019;24(1):350-359.
  6. Mielko KA, Jabłoński SJ, Milczewska J, Sands D, Łukaszewicz M, Młynarz P. Metabolomic studies of Pseudomonas aeruginosa. World J Microbiol Biotechnol. 2019;35(11):178.
  7. Poulsen BE, Yang R, Clatworthy AE, White T, Osmulski SJ, Li L et al. Defining the core essential genome of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 2019 May 14;116(20):10072-80.
  8. Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther. 2022;7(1):199.
  9. Behzadi P, Baráth Z, Gajdács M. It’s Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa. Antibiotics. 2021; 10(1):42.
  10. Botelho J, Grosso F, Peixe L. Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution. Drug Resist Updat. 2019;44:100640.
  11. Brinkman FSL, Winsor GL, Done RE, Filloux A, Francis VI, Goldberg JB et al. The Pseudomonas aeruginosa whole genome sequence: A 20th anniversary celebration. Adv Microb Physiol. 2021;79(1):25-88.
  12. Cho HH, Kwon KC, Kim S, Park Y, Koo SH. Association between Biofilm Formation and Antimicrobial Resistance in Carbapenem-Resistant Pseudomonas Aeruginosa. Ann Clin Lab Sci. 2018;48(3):363-8.
  13. Chadha J, Harjai K, Chhibber S. Revisiting the virulence hallmarks of Pseudomonas aeruginosa: a chronicle through the perspective of quorum sensing. Environ Microbiol. 2022;24(9): 2630-56.
  14. Jami Al-Ahmadi G, Zahmatkesh Roodsari R. Fast and specific detection of Pseudomonas aeruginosa from other pseudomonas species by PCR. Ann Burns Fire Disasters. 2016;29(4):264-7.
  15. Hussain HI, Aqib AI, Seleem MN, Shabbir MA, Hao H, Iqbal Z et al. Genetic basis of molecular mechanisms in β-lactam resistant gram-negative bacteria. Microb Pathog. 2021; doi: 10.1016/j.micpath.2021.105040. doi:10.1016/j.micpath.2021.105040
  16. Marouf S, Li X, Salem HM, Ahmed ZS, Nader SM, Shaalan M, et al. Molecular detection of multidrug-resistant Pseudomonas aeruginosa of different avian sources with pathogenicity testing and in vitro evaluation of antibacterial efficacy of silver nanoparticles against multidrug-resistant P. aeruginosa. Poult Sci. 2023;102(10):102995.
  17. Hugenholtz P, Chuvochina M, Oren A, Parks DH, Soo RM. Prokaryotic taxonomy and nomenclature in the age of big sequence data. ISME J. 2021;15(7):1879-92.
  18. Nikbin VS, Aslani MM, Sharafi Z, Hashemipour M, Shahcheraghi F, Ebrahimipour GH. Molecular identification and detection of virulence genes among Pseudomonas aeruginosa isolated from different infectious origins. Iran J Microbiol. 2012;4(3):118-23.
  19. Dos Santos HR, Argolo CS, Argôlo-Filho RC, Loguercio LL. A 16S rDNA PCR-based theoretical to actual delta approach on culturable mock communities revealed severe losses of diversity information. BMC Microbiol. 2019;19(1):1-4.
  20. Karami P, Mohajeri P, Yousefi Mashouf R, Karami M, Yaghoobi MH, Dastan D et al. Molecular characterization of clinical and environmental Pseudomonas aeruginosa isolated in a burn center. Saudi J Biol Sci. 2019;26(7):1731-6.
  21. Ahmad S, Barik S, Mishra D, Omar BJ, Bhatia M, Singh V. Epidemiology of paediatric pyogenic musculoskeletal infections in a developing country. Sudan J Paediatr. 2022;22(1):54-60.
  22. Chand Y, Khadka S, Sapkota S, Sharma S, Khanal S, Thapa A et al. Clinical Specimens are the Pool of Multidrug- resistant Pseudomonas aeruginosa Harbouring oprL and toxA Virulence Genes: Findings from a Tertiary Hospital of Nepal. Emerg Med Int. 2021;doi: 10.1155/2021/4120697. doi:10.1155/2021/4120697
  23. Sathe N, Beech P, Croft L, Suphioglu C, Kapat A, Athan E. Pseudomonas aeruginosa: Infections and novel approaches to treatment "Knowing the enemy" the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment. Infect Med (Beijing). 2023;2(3):178-94.
  24. Hafiz TA, Bin Essa EA, Alharbi SR, Alyami AS, Alkudmani ZS, Mubaraki MA et al. Epidemiological, Microbiological, and Clinical Characteristics of Multi-Resistant Pseudomonas aeruginosa isolates in King Fahad Medical City, Riyadh, Saudi Arabia. Trop Med Infect Dis. 2023;8(4):205.
  25. de Oliveira HL, Dias GM, Neves BC. Genome sequence of Pseudomonas aeruginosa PA1-Petro-A role model of environmental adaptation and a potential biotechnological tool. Heliyon. 2022;8(11):e11566.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2025 Journal of Pakistan Society of Internal Medicine.